Purpose: Subconjunctival fibroblasts play a critical role in scarring and t
reatment failure in fistulizing surgery for glaucoma The proliferation of s
ubconjunctival fibroblasts appears to be modulated by topical glaucoma medi
cations. This study was conducted to evaluate the effects of latanoprost an
d brimonidine on subconjunctival fibroblast proliferation in rabbit eyes.
Methods: Twelve pigmented Dutch-belted rabbits were divided into treatment
groups of four: latanoprost 0.005%, brimonidine 0.2%, or balanced saline so
lution (BSS) each were administered to one treatment group, both eyes of ea
ch rabbit, twice a day, 6 days a week for 10 weeks. The eyes were then enuc
leated along with the conjunctiva, fixed, processed, and evaluated by light
microscopy and immunohistochemistry using anti-proliferating cell nuclear
antigen (PCNA) and anti-muscle-specific actin antibody (HHF-35). Fibroblast
cell counts were performed at magnification x40.
Results: In all groups, few inflammatory cells were seen in the subconjunct
ival space under light microscopy. PCNA staining revealed a statistically s
ignificant increase in the mean number of labeled fibroblasts in the group
receiving brimonidine compared with the control (BSS) group. The. group rec
eiving latanoprost also had a significantly higher mean number of labeled f
ibroblasts than the groups receiving brimonidine or BSS. Only a few fibrobl
asts stained positively with the anti HHF antibody. Eyes treated with latan
oprost, however, had significantly higher numbers of positively labeled cel
ls than eyes treated with brinonidine or BSS.
Conclusion: When applied to rabbit eyes, latanoprost and brimonidine appear
to increase the number of positively labeled proliferating subconjunctival
fibroblasts.